Cassava’s Shares Plunge as Alzheimer’s Drug Fails Phase III
After promising to set the record straight on the potential of simufilam to help with Alzheimer’s disease, Cassava Sciences reported...
Cassavas
After promising to set the record straight on the potential of simufilam to help with Alzheimer’s disease, Cassava Sciences reported...
